BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35368255)

  • 21. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of high-fat diet on cerebral pathological changes of cerebral small vessel disease in SHR/SP rats.
    Zhang Y; Sheikh AM; Tabassum S; Iwasa K; Shibly AZ; Zhou X; Wang R; Bhuiya J; Abdullah FB; Yano S; Aoki Y; Nagai A
    Geroscience; 2024 Feb; ():. PubMed ID: 38319539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of N-Acetylcysteine on cerebral amyloid-β plaques and kidney damage in spontaneously hypertensive stroke-prone rats.
    Bueche CZ; Garz C; Stanaszek L; Niklass S; Kropf S; Bittner D; Härtig W; Reymann KG; Heinze HJ; Carare RO; Schreiber S
    J Alzheimers Dis; 2014; 42 Suppl 3():S305-13. PubMed ID: 24898644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
    Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
    J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic Profile of Blood-Brain Barrier Remodeling in Cerebral Amyloid Angiopathy.
    Situ M; Citalan-Madrid AF; Stamatovic SM; Keep RF; Andjelkovic AV
    Front Cell Neurosci; 2022; 16():931247. PubMed ID: 35813502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition.
    Fan R; DeFilippis K; Van Nostrand WE
    J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
    Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
    Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
    Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice.
    Foidl BM; Humpel C
    Brain Behav Immun; 2019 May; 78():52-64. PubMed ID: 30664922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
    Haglund M; Kalaria R; Slade JY; Englund E
    Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
    Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F
    Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review: sporadic cerebral amyloid angiopathy.
    Attems J; Jellinger K; Thal DR; Van Nostrand W
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):75-93. PubMed ID: 20946241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
    Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
    Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report].
    Yamashita M; Yamamoto T; Yamada M; Okino S; Fujita T
    Rinsho Shinkeigaku; 2002 Jun; 42(6):530-5. PubMed ID: 12607981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Cerebral Microbleeds in the APP23-Transgenic Mouse Model of Cerebral Amyloid Angiopathy-A 9.4 Tesla MRI Study.
    Reuter B; Venus A; Heiler P; Schad L; Ebert A; Hennerici MG; Grudzenski S; Fatar M
    Front Aging Neurosci; 2016; 8():170. PubMed ID: 27458375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
    Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
    J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.